CHRIS BICKEL, SCIENCE TRANSLATIONAL MEDICINEThe technique: Researchers at MIT and the University of California, San Diego, have programmed a probiotic Escherichia coli strain to detect cancer metastases in the liver. The team used these bacteria, described this week (May 27) in Science Translational Medicine, to detect cancer in mice.
“There are so many bacteria in our own bodies,” said lead author Tal Danino, a postdoc in Sangeeta Bhatia’s lab at MIT. “In some ways, they are a very natural delivery vehicle for agents for diagnosis.”
The new diagnostic technique takes advantage of an old finding: bacteria thrive in tumors. Tumors are filled with nutrients released from dying cells and relatively free of immune cells. So the researchers fed the engineered E. coli to mice and found that the bacteria indeed homed to liver tumors and multiplied.
The gastrointestinal tract is connected to the liver through the portal vein system, Danino explained. “If you orally deliver bacteria, a lot of them will end up in the liver.”
To make the E. coli signal their presence, ...